Dermapharm Holding SE (DMPHF)

Market Cap	2.69B +20.7%
Revenue (ttm)	1.36B -1.4%
Net Income	166.27M +39.2%
EPS	3.09 +39.3%
Shares Out	n/a
PE Ratio	16.18
Forward PE	16.52
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	53.00
Previous Close	53.00
Day's Range	53.00 - 53.00
52-Week Range	48.60 - 59.00
Beta	0.88
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About Dermapharm Holding SE

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China. The company operates through three segments: Branded Pharmaceuticals; Other Healthcare Products; and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1991
• Employees: 3,503
• Stock Exchange: OTCMKTS
• Ticker Symbol: DMPHF

Financial Performance

In 2025, Dermapharm Holding SE's revenue was 1.18 billion, a decrease of -1.43% compared to the previous year's 1.20 billion. Earnings were 132.41 million, an increase of 16.37%.

Financial numbers in EUR

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jun 26, 2026

Data Sources Report a data error